DPPG2-TSL-DOX

doxorubicin-loaded temperature-sensitive liposome · Therosome GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DPPG2-TSL-DOX, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma [Phase 1]